Gout tophi totally disappeared and renal function remained stable. The patient continues to receive rasburicase treatment. P Richette is a Rheumatologist and T Bardin is a Professor of ...
Researchers compared rates of gout medication initiation among patients with gout and type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists.
The current target of gout treatment is to reduce levels down to 6 mg/dL or less. SEL-212 is based on a uricase enzyme (pegadricase) that breaks down uric acid in the blood combined with an immune ...
Optimizing urate-lowering therapy to achieve target serum urate levels may not harm, and may benefit, patients with gout and CKD. Despite clinician concerns, treating patients with gout and stage 3 ...